Dare Bioscience Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.07

+0.02 (+0.98%)

As of Jun 23, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +99.0% upside

Low Target $2.96

Average Target $4.12

High Target $5.49

Current Price $2.07

Current
$2.07

Target
$4.12

$2.96 $4.12 avg $5.49

Scenario Analysis

Bear Case

$2.96

43.0%

Low target

Base Case

$4.12

+99.0%

Avg target

Bull Case

$5.49

+165.2%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$9.19

-77.5% from high

52-Week Low

$1.27

+63.0% from low

Target vs 52W High

$4.12

-55.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+19.1%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+24.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+32.1%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+41.0%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+217.3%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+168.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-33.2%